跳至主要内容
临床试验/JPRN-UMIN000052214
JPRN-UMIN000052214招募中Unknown

A Study on the Safety and Efficacy of Tirzepatide in People with Type 2 Diabetes - A Study on the Safety and Efficacy of Tirzepatide in People with Type 2 Diabetes

Kitasato University0 个研究点目标入组 50 人开始时间: 2023年9月14日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Individuals with severe anemia (Hb < 10g/dL) 2. Patinets with implanted medical devices (such as pacemakers) 3. Patients with active malignant tumors 4. Participants for whom the Principal Investigator or Sub-Investigator has determined are not suitable for participation in this clinical study.

研究者

相似试验